Cargando…
High Levels of miR-7-5p Potentiate Crizotinib-Induced Cytokilling and Autophagic Flux by Targeting RAF1 in NPM-ALK Positive Lymphoma Cells
SIMPLE SUMMARY: Anaplastic lymphoma kinase positive anaplastic large cell lymphomas are a pediatric disease, which still needs treatment improvement. Crizotinib was the first ALK-targeted inhibitor used in clinics, but relapses are now known to occur. Current research efforts indicate that combined...
Autores principales: | Sorrentino, Domenico, Frentzel, Julie, Mitou, Géraldine, Blasco, Rafael B., Torossian, Avédis, Hoareau-Aveilla, Coralie, Pighi, Chiara, Farcé, Manon, Meggetto, Fabienne, Manenti, Stéphane, Espinos, Estelle, Chiarle, Roberto, Giuriato, Sylvie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7650725/ https://www.ncbi.nlm.nih.gov/pubmed/33066037 http://dx.doi.org/10.3390/cancers12102951 |
Ejemplares similares
-
Targeting autophagy enhances the anti-tumoral action of crizotinib in ALK-positive anaplastic large cell lymphoma
por: Mitou, Géraldine, et al.
Publicado: (2015) -
Blockade of crizotinib-induced BCL2 elevation in ALK-positive anaplastic large cell lymphoma triggers autophagy associated with cell death
por: Torossian, Avedis, et al.
Publicado: (2019) -
Crosstalk between microRNA and DNA Methylation Offers Potential Biomarkers and Targeted Therapies in ALK-Positive Lymphomas
por: Hoareau-Aveilla, Coralie, et al.
Publicado: (2017) -
Doxorubicin-induced loss of DNA topoisomerase II and DNMT1- dependent suppression of MiR-125b induces chemoresistance in ALK-positive cells
por: Congras, Annabelle, et al.
Publicado: (2018) -
The Dual Role of Autophagy in Crizotinib-Treated ALK(+) ALCL: From the Lymphoma Cells Drug Resistance to Their Demise
por: Espinos, Estelle, et al.
Publicado: (2021)